Viewing Study NCT03942120


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-02-24 @ 6:45 PM
Study NCT ID: NCT03942120
Status: COMPLETED
Last Update Posted: 2025-04-27
First Post: 2019-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
Sponsor: Janssen Korea, Ltd., Korea
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module